Literature DB >> 26781520

Evolution of endovascular stroke therapies and devices.

Adam N Wallace1, Akash P Kansagra1, James McEachern1, Christopher J Moran1, Dewitte T Cross1, Colin P Derdeyn2.   

Abstract

Acute ischemic stroke is caused by occlusion of a cerebral artery, resulting in loss of brain tissue and neurologic deficits. However, a portion of the ischemic brain can be salvaged if blood flow is restored within an appropriate time frame. The past year has seen the publication of five positive randomized controlled trials demonstrating substantial benefit of mechanical thrombectomy in select patients with large vessel cerebrovascular occlusion. This progress is related to several factors, but most importantly, dramatic improvements in speed and rates of recanalization with the latest generation devices. In this article, we review the evolution of endovascular acute ischemic stroke therapies and key design features of the most widely used devices.

Entities:  

Keywords:  Stroke; catheter; endovascular; stentriever; technique; thrombectomy

Mesh:

Year:  2016        PMID: 26781520     DOI: 10.1586/17434440.2016.1143772

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  3 in total

1.  Comparison of Vacuum Pressures and Forces Generated by Different Catheters and Pumps for Aspiration Thrombectomy in Acute Ischemic Stroke.

Authors:  Michael T Froehler
Journal:  Interv Neurol       Date:  2017-05-18

Review 2.  Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond.

Authors:  Xiaoli Wang; Guoyi Li; Jingkang Guo; Zhiping Zhang; Shuzhang Zhang; Yudan Zhu; Jiwei Cheng; Lu Yu; Yonghua Ji; Jie Tao
Journal:  Front Neurosci       Date:  2020-01-14       Impact factor: 4.677

3.  In vitro P38MAPK inhibition in aged astrocytes decreases reactive astrocytes, inflammation and increases nutritive capacity after oxygen-glucose deprivation.

Authors:  Miren Revuelta; Amaia Elicegui; Till Scheuer; Stefanie Endesfelder; Christoph Bührer; Leire Moreno-Cugnon; Ander Matheu; Thomas Schmitz
Journal:  Aging (Albany NY)       Date:  2021-02-09       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.